Monitor for a subsequent prospectus supplement or takedown announcement, which would specify the size and pricing of any offering. The shelf being effective means the company can move quickly to raise capital, creating near-term dilution risk.
Price Chart
Executive Summary
The SEC declared effective FibroBiologics' shelf registration (File No. 333-284077) on October 19, 2026, under the 1933 Act. This allows the company to offer and sell securities at its discretion, creating potential dilution overhang for existing common shareholders.
Key Facts
- Effectiveness date: October 19, 2026
- SEC File Number: 333-284077
- Shelf registration under 1933 Act
- Company is a clinical-stage biopharmaceutical (SIC 2834)
- No specific offering size or terms disclosed in the EFFECT notice
Financial Impact
Undisclosed — shelf registration enables future capital raises of any size at management's discretion
Risk Factors
- Potential dilutive equity offering at any time
- Clinical-stage company with no approved products may need to raise capital to fund operations
- No stated use of proceeds or offering size limits the ability to assess dilution magnitude
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003284 |
| Document: 9999999995-26-003284-index.html | 9999999995-26-003284 |
| Document: 9999999995-26-003284.txt | 9999999995-26-003284 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | EFFECT | $0.9199 | awaiting T+5 | — | $0.9221 (−0.24%) |
Oct 20, 2026 6d ago | EFFECT | $0.9199 | awaiting T+5 | — | $0.9221 (−0.24%) |
Oct 8, 2026 17d ago | 8-K | $1.13 $0.9710 | ▲ +14.07% | ▲ +12.10% | $0.9221 (+18.40%) |
Sep 15, 2026 5w ago | 8-K | $1.44 $1.43 | ▼ −0.69% | ▼ −1.51% | $0.9221 (−35.97%) |
Aug 24, 2026 9w ago | 8-K | $1.35 $1.72 | ▲ +27.41% | ▲ +26.94% | $0.9221 (−31.70%) |
Jul 31, 2026 12w ago | Press Release | $0.7910 $0.9800 | ▲ +23.89% | ▲ +21.87% | $0.9221 (+16.57%) |
Jul 17, 2026 14w ago | EFFECT | $0.8349 $0.7355 | ▲ +11.91% | ▲ +11.22% | $0.9221 (−10.44%) |
Jul 9, 2026 15w ago | 8-K | $0.8610 $0.8398 | ▼ −2.46% | ▼ −2.33% | $0.9221 (+7.10%) |
Jun 29, 2026 16w ago | 8-K | $0.9477 $0.8687 | ▲ +8.34% | ▲ +8.94% | $0.9221 (+2.70%) |
May 11, 2026 24w ago | Press Release | $0.9900 $1.09 | ▲ +10.10% | ▲ +10.19% | $0.9221 (−6.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers